TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Alphramedic AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,947
|
4,256
|
3,808 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,083
|
540
|
591 |
| EBITDA |
1,059
|
539
|
591 |
| Total assets |
3,502
|
3,007
|
2,393 |
| Current assets |
3,502
|
3,007
|
2,393 |
| Current liabilities |
362
|
353
|
308 |
| Equity capital |
3,140
|
2,654
|
2,085 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.7%
|
88.3%
|
87.1% |
| Turnover per employee |
2,974
|
2,128
|
1,904 |
| Profit as a percentage of turnover |
18.2%
|
12.7%
|
15.5% |
| Return on assets (ROA) |
30.9%
|
18.0%
|
24.7% |
| Current ratio |
967.4%
|
851.8%
|
776.9% |
| Return on equity (ROE) |
34.5%
|
20.3%
|
28.3% |
| Change turnover |
1,615
|
177
|
725 |
| Change turnover % |
37%
|
4%
|
23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.